Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Acme United Reports 10% Increase in Net Sales for the Fourth Quarter of 2024

In This Article:

Acme United Corporation
Acme United Corporation

Net income on an adjusted basis increased 9% in the fourth quarter and 23% for the year

SHELTON, Conn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended December 31, 2024 were $45.9 million compared to $41.9 million in the fourth quarter of 2023, an increase of 10%. Net sales for the year ended December 31, 2024 were $194.5 million compared to $191.5 million in 2023, an increase of 2%. Excluding the impact of the sale of the Camillus and Cuda hunting and fishing product lines on November 1, 2023, net sales for 2024 increased 6% compared to 2023.

Net income for the quarter ended December 31, 2024 was $1.70 million, or $0.41 per diluted share, compared to $1.56 million, or $0.40 per diluted share (as adjusted) for the same period in 2023 an increase of 9% in net income and 3% in diluted earnings per share. Including the net gain recognized on the sale of assets of the Camillus and Cuda business lines on November 1, 2023, net income was $11.2 million, or $2.87 per diluted share for the quarter ended December 31, 2023. Net income for the year ended December 31, 2024 was $10.02 million, or $2.45 per diluted share, compared to $8.15 million, or $2.23 per diluted share (as adjusted), for 2023, an increase of 23% in net income and 10% in diluted earnings per share. Including the net gain recognized on the sale of assets of Camillus and Cuda, net income was $17.8 million, or $4.86 per diluted share, for the year ended December 31, 2023.

Chairman and CEO Walter C. Johnsen said, “Acme United delivered a strong year in 2024. Our net sales increased 6% from our core businesses and grew overall despite the sale of the Cuda and Camillus product lines for $19.8 million in November 2023. We successfully reduced costs and implemented productivity improvements that enabled us not only to offset the contribution from the business we sold, but also to generate 23% net income growth.

“Our acquisition of Elite First Aid in May 2024 has given us the products and knowledge to save lives with first responder kits and supplies. This acquisition has been fully integrated into our operations, and we are aggressively working to expand its distribution and sales in 2025.”

Mr. Johnsen added that the Company has strong liquidity and is positioned for further acquisitions and growth in 2025.

For the three months ended December 31, 2024, net sales in the U.S. segment increased 12% compared to the 2023 period. For the year ended December 31, 2024, net sales in the U.S. segment increased 2% compared to 2023. Excluding Camillus and Cuda, net sales for the year ended December 31, 2024 increased 7% compared to 2023.   The sales increases for the three- and twelve-month periods were due to market share gains across multiple product lines.